GN Store Nord (GN) SEB Nordic Seminar presentation summary
Event summary combining transcript, slides, and related documents.
SEB Nordic Seminar presentation summary
5 Feb, 2026Historical innovation and market evolution
Over 150 years of innovation, from telegraphy to hearing aids, Bluetooth headsets, and gaming equipment.
Key milestones include the first telegraphic link to China (1869), entry into hearing aids (1977), and gaming (2022).
Strategic acquisitions such as Jabra, SteelSeries, and Altia Systems expanded product offerings.
Diversified business segments and shared capabilities
Revenue split: ~40% hearing, ~40% enterprise, ~20% gaming.
Product portfolio includes medical-grade hearing aids, enterprise audio/video solutions, and premium gaming equipment.
Shared functions in operations, R&D, finance, digital, and IT drive efficiency.
Market trends and growth drivers
Benefiting from megatrends: healthy aging, hybrid work, mainstream gaming, and demand for personalized experiences.
Global hearing aid market CAGR ~4%; enterprise and gaming equipment markets CAGR 3-5%.
Technology advancements and sustainability influence product design and manufacturing.
Latest events from GN Store Nord
- Hearing business sold to Amplifon for DKK 17B, enabling tech focus and global audiology leadership.GN
M&A announcement16 Mar 2026 - Guiding for 3%-7% organic growth and margin expansion in 2026, led by innovation and cost control.GN
Q4 20255 Feb 2026 - 5% organic growth and margin gains, with strong Hearing and Gaming, guidance confirmed.GN
Q2 202423 Jan 2026 - Record cash flow and margin gains as Hearing outperformed, offsetting mixed divisional growth.GN
Q3 202416 Jan 2026 - Strong EBITDA growth, new board members, and strategic focus on innovation and resilience.GN
AGM 202520 Dec 2025 - Strong 2024 growth and margin gains set the stage for further expansion in 2025.GN
Q4 202417 Dec 2025 - Organic revenue fell 3%, but margin gains and new launches support cautious optimism.GN
Q1 202529 Nov 2025 - EBITA up 46% on margin gains, with Hearing strong and 2025 guidance narrowed amid tariff risks.GN
Q2 202523 Nov 2025 - Q3 2025 saw 1% organic growth, 11% EBITA margin, and strong cash flow, led by Hearing.GN
Q3 202513 Nov 2025